DEAN INVESTMENT ASSOCIATES, LLC - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 258 filers reported holding HAEMONETICS CORP in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
DEAN INVESTMENT ASSOCIATES, LLC ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$1,020,406
-7.1%
11,391
-11.7%
0.17%
-6.7%
Q2 2023$1,098,476
+74.7%
12,902
+69.8%
0.18%
+79.0%
Q1 2023$628,734
+0.2%
7,598
-4.7%
0.10%
-6.5%
Q4 2022$627,312
+11.0%
7,976
+4.4%
0.11%
-7.0%
Q3 2022$565,000
+15.5%
7,638
+1.7%
0.12%
+21.1%
Q2 2022$489,000
-38.2%
7,509
-40.0%
0.10%
-33.1%
Q1 2022$791,000
-34.1%
12,514
-44.7%
0.14%
-33.0%
Q4 2021$1,201,000
-10.6%
22,648
+19.1%
0.21%
-16.2%
Q3 2021$1,343,000
-3.6%
19,021
-9.0%
0.25%
-1.6%
Q2 2021$1,393,000
-3.9%
20,897
-49.7%
0.26%
-27.2%
Q3 2014$1,450,000
-1.0%
41,5250.0%0.35%
+4.4%
Q2 2014$1,465,00041,5250.34%
Other shareholders
HAEMONETICS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders